Medtec上海国际医疗器械设计与制造技术展览会

2025. 09.24-26
上海世博展览馆1号馆&2号馆

2026. 9.1-9.3

上海新国际博览中心 N1-N4

距离展会

Wearables for medical engineering

Wearable patches – small electronic devices that are affixed to the skin like a patch. 

3-6-1

Wearables are booming – forecast to double in size in the coming three years from currently 200 million units annually. Wristables, i.e. smart watches or sports trackers, are the most common wearables today. Going forward, Covestro expects wearable patches to take off, as they’re flat, flexible and non-invasive. Wearable Technologies estimates the global wearable patch market to reach an annual sales value of 4.4 billion USD by 2020 (1). Market affordability and user acceptance are the main challenges.

Covestro is positioned at the forefront of this development, addressing these unmet needs. Leveraging its long experience in the medical industry with regard to patient’s comfort and converter processing efficiency (speed, flexibility and cost), Covestro enables wearable patch development with its know-how and roll-stock thermoplastic materials. 

Prototype for medical diagnostics

At Compamed, Covestro will show a working prototype of a smart patch, packed with sensors, measuring humidity, temperature, e.g. discomfort-index or heat-stroke alarm, furthermore geo-magnetics, acceleration, pressure, e.g. fall-down alarm, environmental stress meter, and UV/ambient light.

With a growing population, longer life expectancy, and the rise of the middle class, patches will become more important for medical diagnostics and treatments. 

Covestro is a full solution provider of customized polyurethane films and raw materials for adhesives and foams to address both the patch fixation and embedding of electronics functions.

Customized product solutions

Platilon® TPU blown film is sought after for its comfort, e.g. breathability, stretch, soft haptics, hypoallergenics, design (e.g. printable, colors) and customisation to fit the converter’s production process, e.g. thickness range, tailored carriers and release force. Additional functionality includes low melting (95-105 deg C) or water vapor barrier.

Baymedix® adhesives are skin-friendly, breathable and solvent-free. The peel strength can be adjusted for low trauma removal. Baymedix® thermoplastic foam is used for direct embedding of sensitive electronics. The roll-stock process replaces wet chemistry, enabling faster prototyping and modular production. The breathable white foam has gentle haptics, and can be processed with heat and pressure.

About Covestro:

With 2015 sales of EUR 12.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. Covestro, formerly Bayer MaterialScience, has 30 production sites around the globe and as of the end of 2015 employed approximately 15,800 people (full-time equivalents).

Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/CovestroGroup

From:Covestro

Medtec上海展|从射频到冷冻,再到脉冲电场:房颤消融技术的第三次跃迁

Medtec上海展留意到过去几年,在全球电生理领域的学术会议上,一个技术名词被频繁提及——PFA(Pulse Field Ablation,脉冲电场消融)。

从欧美大型电生理中心,到亚洲越来越多开展房颤消融的医院,这项技术正在迅速进入临床视野。越来越多专家认为,PFA的出现不仅仅是一次技术升级,更可能意味着房颤消融领域的一次重要转折。

查看更多 »

上海医疗器械博览会|“介入无植入”药物球囊DCB全面逆袭:新证据、新指南、新战场

上海医疗器械博览会关注到系统回顾冠状动脉药物涂层球囊(DCB)在冠心病介入治疗中的发展历程、作用机制、核心适用范围与扩展应用。DCB通过“无植入”策略,避免永久金属支架带来的血栓与再狭窄风险,已在支架内再狭窄(ISR)治疗中确立有效性,并在小血管病变、分叉病变、弥漫长病变、急性冠脉综合征(ACS)、糖尿病与高出血风险人群中展现出广阔潜力。多项随机研究与真实世界数据表明,DCB在特定适应症下可与药物支架(DES)疗效相当甚至优于DES。DCB治疗效果高度依赖病变准备质量,强调使用影像指导、非顺应球囊、切割球囊或旋磨等策略。尽管当前仍需更多高质量前瞻性研究来验证其在非ISR病变中的长期安全性与有效性,但DCB正逐步成为冠脉介入治疗中的重要工具。

查看更多 »

Medtec上海展|国内主要瓣膜玩家与行业突破口浅析

Medtec上海展注意到近年,经皮主动脉瓣膜置换(TAVR)/经皮主动脉瓣膜植入(TAVI)相关的器械赛道非常火热。对于临床医生而言,手里的武器库多了是好事,这意味着更多的器械选择。但是,对于TAVR器械厂家(尤其是对于:还处于研发/动物实验/临床试验/拿证前的厂家和/或者产品线相对单一的厂家)而言,可能就意味着压力较大了。本文对国内TAVR市场中国际及国内TAVR主要玩家进行了较详尽的梳理和分析。水平所限,难免谬误/挂一漏万,请各位同道指正。

查看更多 »